• Globe Newswire

Boehringer Ingelheim licenses preclinical antibody program from Immunitas Therapeutics to advance treatments for chronic inflammatory diseases

Globenewswire -

• Globe Newswire

Teva to Acquire Emalex Biosciences, Adding NDA-Ready, First-in-Class Therapy to Neuroscience Pipeline and Accelerating Teva’s Pivot to Growth Strategy

Globenewswire -

• Globe Newswire

Kymeta™ Unveils Kestrel™ u5: First-of-Its-Kind Satellite Terminal Delivering Unmatched Compact Performance

Globenewswire -

• Globe Newswire

Spring Bio Solution Launches NCE Grid to decode Para IV Filing and First-to-File Opportunities

Globenewswire -

• Globe Newswire

Chengdu Origen and Vanotech Announce First Patient Dosed in VAN-2401 Phase 1 Trial of Gene Therapy for Wet Age-Related Macular Degeneration

Globenewswire -

• Globe Newswire

Luxury Fertility & Surrogacy Concierge, First-of-Its-Kind.

A new paradigm in which luxury fertility is an experience. Because the world's wealthy don't have time to create their families, as they're busy creating...

• Globe Newswire

Luxury Fertility & Surrogacy Concierge, First-of-Its-Kind. IMA ART Fertility